Insulin Resistance: The Root Problem Behind Modern Disease

Most people think insulin resistance only matters once someone develops prediabetes or type 2 diabetes. That belief misses the bigger picture. Insulin resistance often begins years if not decades earlier and quietly drives many of the chronic diseases affecting adults across the UK.

Insulin is a hormone made by the pancreas. Its role is simple. It helps move glucose from the bloodstream into cells so the body can use it for energy. When cells stop responding properly to insulin, the body compensates by producing more. Blood sugar often stays normal at this stage. Insulin levels do not.

This creates a hidden metabolic problem. High insulin circulates for years without symptoms, slowly altering how the body stores fat, manages energy, and regulates inflammation.

By the time blood sugar rises and a diagnosis appears, the damage has usually been building for a decade or longer.

The scale of the issue is significant. Diabetes UK estimates that around 4.6 million people in the UK live with diagnosed diabetes, with roughly 90 percent being type 2. A further 1.3 million people are believed to have diabetes without knowing it. In addition, around 6.3 million adults are classed as having prediabetes or being at increased risk.

That places over 11 million people on the metabolic disease spectrum, and those figures only reflect what is measured.

Insulin resistance is rarely tested as standard. Fasting insulin is not routinely included in NHS blood panels. Instead, diagnosis waits until blood glucose rises enough to cross a threshold. Research settings use markers such as HOMA-IR, triglyceride to glucose indices, and lipid ratios to estimate insulin resistance. These tools consistently show metabolic dysfunction long before diabetes develops.

Large UK Biobank studies have confirmed that higher insulin resistance scores strongly predict future disease. People with elevated insulin resistance markers show increased risk of heart disease, fatty liver disease, kidney disease, stroke, and cognitive decline, even when blood sugar remains within normal ranges.

This matters because insulin resistance affects far more than glucose control.

High insulin locks the body into fat storage mode. Fat burning becomes difficult. Hunger and cravings increase. Energy dips become common. Inflammation rises. Blood pressure increases. Cholesterol patterns shift toward higher risk profiles.

These changes explain why insulin resistance sits beneath many of the UK’s leading causes of death.

Office for National Statistics data from 2023 shows that over 40 percent of deaths in England and Wales are linked to conditions associated with poor metabolic health. These include heart disease, stroke, dementia, respiratory disease, and certain cancers. Diabetes rarely appears as the immediate cause of death, yet insulin resistance contributes to many of these outcomes years earlier.

Diet plays a major role. Many people assume smoothies and fruit-based drinks are harmless. A single well-known branded smoothie can contain 25 to 30 grams of sugar in one bottle, equivalent to six teaspoons of sugar. While this sugar comes from fruit, it still drives insulin release when consumed in liquid form. Frequent spikes reinforce insulin resistance over time, especially when combined with stress, poor sleep, and inactivity.

Insulin resistance develops silently. Blood tests often look fine. Weight gain may be slow or limited to the abdomen. Fatigue gets blamed on age or workload. By the time blood sugar rises, the system has already been under strain for years.

The encouraging truth is that insulin resistance responds well to early action. Real food. Fewer liquid sugars. Adequate protein. Strength and movement. Sleep. Stress management. These shifts target the mechanism itself, not just the symptom.

Metabolic health starts long before diagnosis. Waiting for diabetes misses the opportunity for prevention. Insulin resistance is not a future problem. It is a present one, hiding in plain sight.